Pliant Therapeutics Reports Q2 2026 Financial Results

What Happened Pliant Therapeutics, Inc. announced its financial results for the quarter ended June 30, 2026 by issuing a press release on August 11, 2026. The company filed a Current Report on Form 8‑K (Item 2.02) to furnish that press release; the release itself is included as Exhibit 99.1 to the 8‑K. The filing states the furnished information is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other securities filings.

Key Details

• Filing date: August 11, 2026 (Form 8‑K, Item 2.02: Results of Operations and Financial Condition).
• Quarter covered: Q2 2026 (period ended June 30, 2026).
• Exhibit: 99.1 — press release announcing the company’s Q2 2026 financial results.
• Administrative: Form signed by Keith Cummings, M.D., MBA, Chief Financial Officer, on August 11, 2026.

Why It Matters This 8‑K signals that Pliant has published its quarterly earnings and related financial details; those results can directly affect the company’s stock, outlook, and investor decisions. Retail investors should read the furnished press release (Exhibit 99.1) and any accompanying earnings materials to see revenue, net loss, cash runway, and management commentary. For full official financial statements and additional disclosures, check the company’s subsequent SEC filings and investor relations materials.